Monthly Archives: January 2008

Sun Pharma launches generic Protonix ® Tablets

January 30th, 2008|

Sun Pharmaceutical Industries has commercially launched generic Pantoprazole Sodium Delayed Release (DR) Tablets, 40 mg, which is AB-rated to Wyeth's Protonix® DR Tablets.   

Baxter recalls Heparin 1,000 Units/ml 10

January 30th, 2008|

Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/ml 10 and 30ml Multi-Dose Vials

Glenmark receives US FDA approval for its semi-solids manufacturing plant at Baddi

January 29th, 2008|

India's Glenmark Pharmaceuticals Ltd said it received approval from the US Food and Drug Administration for its facility at Baddi in the northern Indian state of Himachal Pradesh, which manufactures ointments and creams.

Gastrotech signs in-license agreement with Eli Lilly to develop and market GTP-010

January 29th, 2008|

Gastrotech signs Licensing Agreement with Eli Lilly following Positive Clinical Data on Compound for Irritable Bowel Syndrome

Environmental biotech products to reach $261.3 million by 2013 in US

January 29th, 2008|

Advances technological has shaped and nature has been transformed by science and offers us unlimited potential in using environmental biotechnology – the US market for environmental biotechnology products for waste treatment is expected to be worth $180.2 million in 2008.

EU approves Roche Avastin for wider use

January 29th, 2008|

Swiss drugmaker Roche's key drug Avastin has received the approval for wider use to treat metastatic colorectal cancer in the European Union.

Make India a significant player in nanotechnology: Kalam

January 29th, 2008|

Government and private sector should join hands and carry out focused research to make India a significant player in nanotechnology said former President A P J Abdul Kalam at the conference at the National Institute of Technology at Warangal. 

Licence of 4 drug firms supended

January 29th, 2008|

Union health ministry has suspended the manufacturing licence of four leading state-owned drug makers for violating the good manufacturing practices (GMP)

Sanofi-aventis’s anticoagulant approved in Japan

January 29th, 2008|

Sanofi-aventis’s  anticoagulant Clexane® (enoxaparin sodium injection) has been approved for marketing in Japan by the Ministry of Health, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing orthopaedic surgery of the lower limbs such as total hip replacement, total knee replacement and hip fracture surgery.

NPPA revises prices of Bulk drugs

January 25th, 2008|

The National Pharmaceutical Pricing Authority has revised the prices of Aspirin, Sulphamethaxazole, Norfloxacin and Pyrantel Pamoate 

Zydus Cadila collaborates with Prolong Pharmaceuticals for Drug Discovery and Development

January 25th, 2008|

Zydus Cadila, an innovative global pharmaceutical company, and Prolong Pharmaceuticals Inc., a US-based, venture-backed drug delivery research and development company is collaborating for the development of a next generation therapeutic protein, ‘PEG-EPO’, for the treatment of severe anemia. 

Matrix acquires residual stake MChem group of companies

January 25th, 2008|

Matrix Laboratories, has acquired the residual stake in Mchem group of companies, China

Shreya to market Generex’s oral spray insulin in India

January 22nd, 2008|

Shreya Life Sciences to market launch activities for Generex Oral-lyn, the non-injectable buccal insulin, from the Canada-based Generex Biotechnology Corporation in India.

Roche acquires Ventana

January 22nd, 2008|

Roche a world-leading healthcare provider of pharmaceuticals and diagnostics, and Ventana Medical Systems have signed a definitive merger agreement.

10 % price hike only from April 07: NPPA

January 22nd, 2008|

The National Pharmaceutical Pricing Authority (NPPA) has revised the guidelines for monitoring of prices of non-scheduled formulations, making the 10 percent ceiling in prices effective only from April 1, 2007, instead of January 2007

Herbal cure for Type II diabetes granted patent

January 22nd, 2008|

Suresh Sharma of Jaipur develops medicine from Kadamb tree  – cure for Type II diabetes

Aurobindo Pharma gets US FDA nod for Cefdinir Capsules

January 22nd, 2008|

Aurobindo Pharma has received approval from the US Food and Drug Administration (FDA) to market its 300 mg Cefdinir Capsules.

Speedel Holding’s Spp100 combo-pack gets US FDA approval

January 21st, 2008|

Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic has receives US Approval for treatment of High Blood Pressure

Ranbaxy settles Imitrex litigation with GSK

January 21st, 2008|

 Ranbaxy Laboratories has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version of GlaxoSmithKline's Imitrex Tablets.

BioAsia 2008

January 21st, 2008|

Indian Vice President Mr. Hamid Ansari will inaugurate the fifth edition of BioAsia 2008 which is scheduled to be held from February 7th  to 9th  2008 in Hyderabad.